dr kirtane on an investigation of tils plus pembrolizumab in advanced hnscc
Published 1 month ago • 33 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
1:20
dr kirtane on the design of a phase 1b trial of tbio4101 plus pembrolizumab in hnscc
-
11:47
pembrolizumab in hnscc
-
5:34
pembrolizumab for recurrent hnscc
-
1:52
safety of bca101, an egfr/tgfβ inhibitor, with pembrolizumab in hnscc
-
0:51
dr. machiels on pembrolizumab and chemoradiation in hnscc
-
6:51
pembrolizumab and nivolumab in recurrent hnscc
-
5:56
patient selection in treating hnscc
-
0:58
dr. machiels on pembrolizumab in head and neck cancer
-
2:13
nivolumab in hnscc
-
1:41
dr. bauml on keynote-055 study for patients with hnscc
-
1:36
addition of an egfr/tgfβ inhibitor with pembrolizumab in head and neck cancer
-
1:41
phase ii trial of pembrolizumab and cabozantinib in hnscc
-
3:55
checkpoint inhibitors for recurrent hnscc
-
2:26
sd-101 plus pembrolizumab for hnscc
-
1:40
dr. burtness on the use of biomarkers in metastatic hnscc
-
1:32
dr. cohen on immunotherapy combinations in head and neck cancer
-
1:58
dr. vokes on nivolumab, pembrolizumab approvals in head and neck cancer
-
1:58
dr. rischin on keynote-048 results in head and neck squamous cell carcinoma